Stay updated on Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial
Sign up to get notified when there's something new on the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page.

Latest updates to the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, along with the removal of a government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding affecting updates and the new site version (v3.4.1) were added, while the previous version (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedAdded a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) along with a new Revision: v3.4.0; the previous labels (lowercase met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed. These changes affect only UI text and release metadata and do not alter the core study information or status.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 in the page footer; no other content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page now presents a consolidated Locations section listing North Carolina and Pennsylvania sites, replacing the previous separate location subsections.SummaryDifference0.4%

Stay in the know with updates to Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page.